Table 2.
Clinical outcomes.
| Present series N = 4* | Compiled data (%) 1972–2018 (Noh J etal)4,N = 37 | |
|---|---|---|
| No evidence of disease after treatment** | 2 | 21(57%) |
| Recurred | 1 | 14 (38%) |
| Interval to recurrence (months) |
63 | Median 6.5 (Range 1–48) |
| Site of recurrence | Lung and chest wall −1 | Lung – 5 (36%) Lymph node − 8 (57%) Local recurrence − 4 (20%) Others − 2 (14%) |
| Died of disease | 0 | 14 (38%) |
One patient is undergoing upfront palliative treatment.